Susie X. Sun, MD, MS, CMQ, FACS

Peer-Reviewed Articles

1. Breit, C, Sun, SX. Updates in the Management of Inflammatory Breast Cancer. Current Breast Cancer Reports 17(1), 2025. e-Pub 2025.
2. Wanis KN, Mitchell MP, Giordano SH, Litton JK, Shaitelman SF, Tamirisa N, Bedrosian I, Dong W, Shen Y, Hunt KK, Singh P, Sun SX, Caudle AS, Kuerer HM, Meric-Bernstam F, Hwang RF, Adesoye T. Implications of omitting sentinel lymph node biopsy on adjuvant decision making for patients with small breast cancers. Cancer 131(11):e35910, 2025. e-Pub 2025. PMID: 40433858.
3. Jacomina, LE, Swanson, DM, Mitchell, MP, Woodward, W, Smith, B, Hoffman, K, Goodman, C, Garber, HR, Sun, SX, Yap, TA, Meric-Bernstam, F, Arzu, I, Bloom, ES, Schlembach, PJ, Strom, EA, Stauder, MC, Shaitelman, SF. Outcomes After Palliative Radiation Therapy in Patients With Symptomatic Locoregionally Advanced Breast Cancer. International Journal of Radiation Oncology Biology Physics 122(2):278-291, 2025. e-Pub 2025. PMID: 39549757.
4. Wanis KN, Dong W, Shen Y, Meric-Bernstam F, Adesoye T, Kuerer HM, Caudle AS, Tamirisa N, DeSnyder SM, Sun SX, Bedrosian I, Singh P, Cox SE, Hunt KK, Hwang RF. Predicting pathologic >/=N2 disease in women with breast cancer. NPJ Breast Cancer 11(1):46, 2025. e-Pub 2025. PMID: 40404657.
5. Zaveri S, Sun SX, Zaghloul T, Bevers TB, Albarracin CT, Patel M, Bedrosian I. Trends in Atypical Ductal Hyperplasia Diagnosis and Upgrade: A 20-Year Experience and Impact of MRI Use on Upgrade Rates. Ann Surg Oncol 32(5):3244-3251, 2025. e-Pub 2025. PMID: 39875718.
6. Lynce F, Niman SM, Kai M, Ma SR, Troll E, Li L, Miller KD, Jagsi R, Mason G, Overmoyer BA, Le-Petross HTC, Nakhlis F, Krishnamurthy S, Harrison BT, Sun SX, Yeh ED, Bellon JR, Warren LE, Stauder MC, Regan MM, Woodward WA. Development of a Multi-Institutional Dataset to Validate a Novel Inflammatory Breast Cancer Diagnostic Score. J Natl Cancer Inst, 2025. e-Pub 2025. PMID: 40163681.
7. Zaveri S, Sun SX, Zaghloul T, Bevers TB, Albarracin CT, Patel M, Bedrosian I. ASO Visual Abstract: Trends in Atypical Ductal Hyperplasia Diagnosis and Upgrade-A Twenty-Year Experience and Impact of MRI Use on Upgrade Rates. Ann Surg Oncol 32(5):3339-3340, 2025. e-Pub 2025. PMID: 40080363.
8. Montagna, G, Laws, AD, Ferrucci, M, Mrdutt, MM, Sun, SX, Bademler, S, Balbaloglu, H, Balint-Lahat, N, Banys, M, Barrio, AV, Benson, JR, Beşe, N, Boughey, JC, Boyle, MK, Diego, EJ, Eden, C, Eller, R, Goldschmidt, M, Hlavin, C, Heidinger, M, Jelinska, J, Cakmak, G, Kesmodel, SB, King, TA, Kuerer, HM, Loesch, J, Milardi, F, Murawa, D, Moo, TA, Menes, T, Passeri, D, Pastoriza, J, Perhavec, A, Pislar, N, Polidorio, N, Rami, A, Ryu, JM, Schulz, A, Sevilimedu, V, Ugurlu, MU, Uras, C, van Hemert, A, Wong, SM, Robyn Yoo, TK, Zhang, JQ, Karanlik, H, Cabioglu, N, Vrancken-Peeters, MT, Morrow, M, Weber, W. Nodal Burden and Oncologic Outcomes in Patients With Residual Isolated Tumor Cells After Neoadjuvant Chemotherapy (ypN0i+). Journal of Clinical Oncology 43(7):810-820, 2025. e-Pub 2025. PMID: 39509672.
9. Muppidi N, Adesoye T, Yi M, Sun SX, Chavez-MacGregor M, Singh P, Karuturi M, Tamirisa N, Hunt KK, Teshome M. ASO Visual Abstract: Clinical Outcomes for Early-Stage Node-Negative HER2-Positive Breast Cancer Patients Receiving Upfront Surgery or Neoadjuvant Systemic Therapy. Ann Surg Oncol 32(2):983-984, 2025. e-Pub 2025. PMID: 39562422.
10. Moore, AM, Caudle, A, Sun, SX, Yi, M, Smith, BD, Valero, V, Yang, W, Kuerer, HM, Hunt, KK, Teshome, M. Impact of Clipped Node as a Sentinel Lymph Node on Axillary Staging Following Neoadjuvant Chemotherapy in Clinically Node-Positive Breast Cancer. Annals of surgical oncology 32(1):84-91, 2025. e-Pub 2025. PMID: 39419889.
11. Moore, AM, Caudle, AS, Sun, SX, Yi, M, Smith, B, Valero, V, Yang, W, Kuerer, HM, Hunt, KK, Teshome, M. ASO Visual Abstract. Annals of surgical oncology 32(1):123-124, 2025. e-Pub 2025. PMID: 39443343.
12. Wu Y, Wu PH, Chambliss A, Wirtz D, Sun SX. Unifying fragmented perspectives with additive deep learning for high-dimensional models from partial faceted datasets. NPJ Biol Phys Mech 2(1):5, 2025. e-Pub 2025. PMID: 40012561.
13. Ni Q, Ge Z, Li Y, Shatkin G, Fu J, Sen A, Bera K, Yang Y, Wang Y, Wu Y, Nogueira Vasconcelos AC, Yan Y, Lin D, Feinberg AP, Konstantopoulos K, Sun SX. Cytoskeletal activation of NHE1 regulates mechanosensitive cell volume adaptation and proliferation. Cell Rep 43(12):114992, 2024. e-Pub 2024. PMID: 39579355.
14. Muppidi, N, Adesoye, T, Yi, M, Sun, SX, Chavez-MacGregor, M, Singh, P, Karuturi, MS, Tamirisa, N, Hunt, KK, Teshome, M. Clinical Outcomes in Patients with Early Stage Node-Negative HER2-Positive Breast Cancer Receiving Upfront Surgery or Neoadjuvant Systemic Therapy. Annals of surgical oncology 31(13):8795-8801, 2024. e-Pub 2024. PMID: 39192013.
15. Moore, AM, Caudle, AS, Sun, SX, Yi, M, Smith, B, Valero, V, Yang, W, Kuerer, HM, Hunt, KK, Teshome, M. Residual Nodal Burden After Neoadjuvant Chemotherapy in cN1 Breast Cancer Patients with Positive Nodes at Targeted Axillary Dissection. Annals of surgical oncology 31(11):7264-7270, 2024. e-Pub 2024. PMID: 39044106.
16. Wanis, KN, Goetz, L, So, A, Glencer, AC, Sun, SX, Teshome, M, Resetkova, E, Hwang, RF, Hunt, KK, Candelaria, RP, Huo, L, Singh, P. The Prevalence of Sentinel Lymph Node Positivity and Implications for the Utility of Frozen Section Diagnosis Following Neoadjuvant Systemic Therapy in Patients with Clinically Node-Negative HER2-Positive or Triple-Negative Breast Cancer. Annals of surgical oncology 31(11):7339-7346, 2024. e-Pub 2024. PMID: 39048903.
17. Glencer, AC, Wanis, KN, Brown, S, Lucci, A, Sun, SX, Adesoye, T, DeSnyder, SM, Layman, RM, Woodward, W, Hunt, KK, Teshome, M. Self-Reported Management of Inflammatory Breast Cancer Among the American Society of Breast Surgeons Membership. Annals of surgical oncology 31(11):7326-7334, 2024. e-Pub 2024. PMID: 39034365.
18. Moore AM, Caudle AS, Sun SX, Yi M, Smith BD, Valero V, Yang W, Kuerer HM, Hunt KK, Teshome AM. Residual Nodal Burden After Neoadjuvant Chemotherapy in cN1 Breast Cancer Patients with Positive Nodes at Targeted Axillary Dissection. Ann Surg Oncol, 2024.
19. Wanis KN, Kuerer HM, Sun SX, Hunt KK, Glencer AC, Teshome M, Lucci A, Weiser R, Johnson H, Smith BD, Gutierrez AM, Shaitelman SF, Arun BK. Clinical Outcomes for BRCA Pathogenic Variant Carriers With Breast Cancer Undergoing Breast Conservation. JAMA Netw Open 7(6), 2024. PMID: 38916888.
20. Montagna G, Mrdutt MM, Sun SX, Hlavin C, Diego EJ, Wong SM, Barrio AV, van den Bruele AB, Cabioglu N, Sevilimedu V, Rosenberger LH, Hwang ES, Ingham A, Papassotiropoulos B, Nguyen-Sträuli BD, Kurzeder C, Aybar DD, Vorburger D, Matlac DM, Ostapenko E, Riedel F, Fitzal F, Meani F, Fick F, Sagasser J, Heil J, Karanlik H, Dedes KJ, Romics L, Banys-Paluchowski M, Muslumanoglu M, MDRC P, Díaz MC, Heidinger M, Fehr MK, Reinisch M, Tukenmez M, Maggi N, Rocco N, Ditsch N, Gentilini OD, Paulinelli RR, Zarhi SS, Kuemmel S, Bruzas S, di Lascio S, Parissenti TK, Hoskin TL, Güth U, Ovalle V, Tausch C, Kuerer HM, Caudle AS, Boileau JF, Boughey JC, Kühn T, Morrow M, Weber WP. Omission of Axillary Dissection Following Nodal Downstaging With Neoadjuvant Chemotherapy. JAMA Oncol 10(6):793-798, 2024. e-Pub 2024. PMID: 38662396.
21. Woodfin AA, Yam C, Teshome M, Kuerer HM, Hunt KK, Meric-Bernstam F, Schaverien M, Barcenas CH, Sun SX. Axillary Nodal Metastases Conversion and Perioperative Complications with Neoadjuvant Pembrolizumab Therapy in Triple-Negative Breast Cancer. Ann Surg Oncol 31(2):974-980, 2024. e-Pub 2024. PMID: 37973647.
22. Farley C, Bassett R, Meric-Bernstam F, Bedrosian I, Caudle A, DeSnyder S, Hunt K, Kuerer H, Singh P, Sun S, Tamirisa N, Teshome M, Hwang RF. To Dissect or Not to Dissect: Can We Predict the Presence of Four or More Axillary Lymph Node Metastases in Postmenopausal Women with Clinically Node-Negative Breast Cancer?. Ann Surg Oncol 30(13):8327-8334, 2023. e-Pub 2023. PMID: 37670121.
23. Everidge SA, Sun J, Teshome M, Tamirisa N, Sun S, Adesoye T, Nia E, Bevers T, Bedrosian I, Patel M, Singh P. Lobular Neoplasia Diagnosed by MRI-Guided Breast Biopsy: Identifying Upgrade Rate to Malignancy and Outcomes of Clinical and Surgical Management. Ann Surg Oncol. e-Pub 2023. PMID: 38117388.
24. Zaveri S, Everidge S, FitzSullivan E, Hwang R, Smith BD, Lin H, Shen Y, Lucci A, Teshome M, Sun SX, Hunt KK, Kuerer HM. Extremely Low Incidence of Local-Regional Recurrences Observed Among T1-2 N1 (1 or 2 Positive SLNs) Breast Cancer Patients Receiving Upfront Mastectomy Without Completion Axillary Node Dissection. Ann Surg Oncol 30(12):7015-7025, 2023. e-Pub 2023. PMID: 37458948.
25. Sun SX, Piotrowski MJ, Adesoye T, Mitchell MP, Garber HR, Teshome M, Kuerer HM, Tamirisa N, Singh P. Long-Term Outcomes and Predictors of Response in Breast Cancer Patients with Advanced Nodal Involvement. J Am Coll Surg. e-Pub 2023. PMID: 37870227.
26. Adesoye T, Everidge S, Chen J, Sun SX, Teshome M, Valero V, Woodward WA, Lucci A. Low Rates of Local-Regional Recurrence Among Inflammatory Breast Cancer Patients After Contemporary Trimodal Therapy. Ann Surg Oncol 30(10):6232-6240, 2023. e-Pub 2023. PMID: 37479842.
27. Johnson HM, Lin H, Shen Y, Diego EJ, Krishnamurthy S, Yang WT, Smith BD, Valero V, Lucci A, Sun SX, Shaitelman SF, Mitchell MP, Boughey JC, White RL, Rauch GM, Kuerer HM, Study Group ER. Patient-Reported Outcomes of Omission of Breast Surgery Following Neoadjuvant Systemic Therapy: A Nonrandomized Clinical Trial. JAMA Netw Open 6(9):e2333933, 2023. e-Pub 2023. PMID: 37707811.
28. Sun SX, Duan Z, Kuerer HM, DeSnyder SM, Cunningham C, Zhao H, Giordano SH. Predictors of Emergency Room Visits After Ambulatory Breast Cancer Surgery in the Medicare Population. Ann Surg Oncol 30(3):1689-1698, 2023. e-Pub 2023. PMID: 36402898.
29. Cobb AN, Diao K, Teshome M, Lucci A, Ueno NT, Stauder M, Layman RM, Kuerer HM, Woodward WA, Sun SX. Long-term Oncologic Outcomes in Patients with Inflammatory Breast Cancer with Supraclavicular Nodal Involvement. Ann Surg Oncol 29(10):6381-6392, 2022. e-Pub 2022. PMID: 35834145.
30. Farley CR, Irwin S, Adesoye T, Sun SX, DeSnyder SM, Lucci A, Shaitelman SF, Chang EI, Ueno NT, Woodward WA, Teshome M. Lymphedema in Inflammatory Breast Cancer Patients Following Trimodal Treatment. Ann Surg Oncol 29(10):6370-6378, 2022. e-Pub 2022. PMID: 35854031.
31. Kuerer HM, Smith BD, Krishnamurthy S, Yang WT, Valero V, Shen Y, Lin H, Lucci A, Boughey JC, White RL, Diego EJ, Rauch GM, Trials Group ERC. Eliminating breast surgery for invasive breast cancer in exceptional responders to neoadjuvant systemic therapy: a multicentre, single-arm, phase 2 trial. Lancet Oncol. e-Pub 2022. PMID: 36306810.
32. Andring LM, Diao K, Sun S, Patel M, Whitman GJ, Schlembach P, Arzu I, Joyner MM, Shaitelman SF, Hoffman K, Stauder MC, Smith BD, Woodward WA. Locoregional Management and Prognostic Factors in Breast Cancer With Ipsilateral Internal Mammary and Axillary Lymph Node Involvement. Int J Radiat Oncol Biol Phys 113(3):552-560, 2022. e-Pub 2022. PMID: 35248602.
33. Corkum J, Zhu V, Agbafe V, Sun SX, Chu C, Colen JS, Greenup R, Offodile AC. Area Deprivation Index and Rurality in Relation to Financial Toxicity among Breast Cancer Surgical Patients: Retrospective Cross-Sectional Study of Geospatial Differences in Risk Profiles. J Am Coll Surg 234(5):816-826, 2022. e-Pub 2022. PMID: 35426394.
34. Adesoye T, Sun SX, Schaverien MV, Woodward WA, Lucci A. Immediate Breast Reconstruction in Inflammatory Breast Cancer: Are We There Yet?. Ann Surg Oncol. e-Pub 2022. PMID: 35471749.
35. Perkins, GC, Sun, SX, Middleton, LP. Synchronous bilateral low grade adenosquamous carcinoma with imaging and pathology correlation. Human Pathology Reports 27, 2022. e-Pub 2022.
36. Perkins GC, Sun SX, Middleton LP. Synchronous Bilateral Low Grade Adenosquamous Carcinoma with Imaging and Pathology Correlation. Human Pathology Reports, 2022. e-Pub 2022.
37. Adesoye T, Babayemi O, Postlewait LM, DeSnyder SM, Sun SX, Woodward WA, Ueno NT, Hunt KK, Lucci A, Teshome M. Inflammatory Breast Cancer at the Extremes of Age. Ann Surg Oncol 28(10):5626-5634, 2021. e-Pub 2021. PMID: 34292426.
38. Sun SX, Suk R, Kuerer HM, Cantor SB, Raber BM, Deshmukh AA. No Treatment Versus Partial Mastectomy Plus Radiation for Ductal Carcinoma In Situ. Ann Surg Oncol. e-Pub 2021. PMID: 34467509.
39. Postlewait LM, Teshome M, Adesoye T, DeSnyder SM, Lim B, Kuerer HM, Bedrosian I, Sun SX, Woodward WA, Le-Petross HT, Valero V, Ueno NT, Lucci A. Contralateral Axillary Metastasis in Patients with Inflammatory Breast Cancer. Ann Surg Oncol. e-Pub 2021. PMID: 34125346.
40. Nia ES, Huang ML, Sun SX, Mitchell MP, Myatt JP, Candelaria RP. The mammographic appearance of the BioMonitor implantable loop recorder. Clin Imaging 73:28-30, 2021. e-Pub 2021. PMID: 33296770.
41. Sun SX, van la Parra RFD, Rauch GM, Checka C, Tadros AB, Lucci A, Teshome M, Black D, Hwang RF, Smith BD, Krishnamurthy S, Valero V, Yang WT, Kuerer HM. Patient Selection for Clinical Trials Eliminating Surgery for HER2-Positive Breast Cancer Treated with Neoadjuvant Systemic Therapy. Ann Surg Oncol 26(10):3071-3079, 2019. e-Pub 2019. PMID: 31342361.
42. Greenleaf EK, Sun SX, Hollenbeak CS, Wong J. Minimally invasive surgery for gastric cancer: the American experience. Gastric Cancer 20(2):368-378, 2017. e-Pub 2017. PMID: 26961133.
43. Kulaylat AN, Qin D, Sun SX, Hollenbeak CS, Schubart JR, Aboud AJ, Flemming DJ, Bollard ER, Dillon PW, Han DC. Aligning perceptions of mistreatment among incoming medical trainees. J Surg Res 208:151-157, 2017. e-Pub 2017. PMID: 27993202.
44. Kulaylat AN, Qin D, Sun SX, Hollenbeak CS, Schubart JR, Aboud AJ, Flemming DJ, Dillon PW, Bollard ER, Han DC. Perceptions of mistreatment among trainees vary at different stages of clinical training. BMC Med Educ 17(1):14, 2017. e-Pub 2017. PMID: 28088241.
45. Sun SX, Kulaylat AN, Hollenbeak CS, Soybel DI. Cost-effective Decisions in Detecting Silent Common Bile Duct Gallstones During Laparoscopic Cholecystectomy. Ann Surg 263(6):1164-72, 2016. e-Pub 2016. PMID: 26575281.
46. Sun SX, Hollenbeak CS, Rogers AM. Readmissions Following Gastric Bypass Surgery. Obes Surg 26(2):269-75, 2016. e-Pub 2016. PMID: 26264895.
47. Sun SX, Greenleaf EK, Hollenbeak CS, Leung AM. Attributable cost of obesity in breast surgery: a matched cohort analysis. Am J Surg 210(4):668-77.e1, 2015. e-Pub 2015. PMID: 26212389.
48. Sun SX, Leung AN, Dillon PW, Hollenbeak CS. Length of Stay and Readmissions in Mastectomy Patients. Breast J 21(5):526-32, 2015. e-Pub 2015. PMID: 26104795.
49. Sun SX, Hollenbeak CS, Leung AM. Deviation from the Standard of Care for Early Breast Cancer in the Elderly: What are the Consequences?. Ann Surg Oncol 22(8):2492-9, 2015. e-Pub 2015. PMID: 25515198.
50. Maag R, Sun SX, Hannon M, Davies R, Alagona P, Foy A. Positive predictive value of an elevated cardiac troponin for type I myocardial infarction in ED patients based on the chief complaint. Am J Emerg Med 33(4):516-20, 2015. e-Pub 2015. PMID: 25680564.

Invited Articles

1. Adesoye T, Irwin S, Sun SX, Lucci A, Teshome M. Contemporary surgical management of inflammatory breast cancer: a narrative review. Chin Clin Oncol 10(6):57, 2021. e-Pub 2021. PMID: 35016511.
2. Sun SX, Kuerer HM. ASO Author Reflections: Selecting Patients for Elimination of Surgery Trials-Predicting Residual Invasive and In Situ Disease in Patients with HER2-Positive Breast Cancer After Neoadjuvant Systemic Therapy. Ann Surg Oncol 26(Suppl 3):804-805, 2019. e-Pub 2019. PMID: 31654165.
3. Sun SX, Moseley TW, Kuerer HM, Yang WT. Imaging-Based Approach to Axillary Lymph Node Staging and Sentinel Lymph Node Biopsy in Patients With Breast Cancer. AJR Am J Roentgenol:1-10. e-Pub 2019. PMID: 31714846.
4. Sun SX, Kulaylat AN, Hollenbeak CS, Soybel DI. Reply to Letter: "Cost-Effective Decisions in Managing Silent Common Bile Duct Stones Should Include all the Management Options to Help Decision Makers". Ann Surg 266(6):e90-e91, 2017. e-Pub 2017. PMID: 28257325.
5. Grant SB, Hon H, Iver P, Smith C, Sun SX. The RAS-ACS: Recruiting medical students and training future leaders. Bull Am Coll Surg 100(8):23-8, 2015. e-Pub 2015. PMID: 26419051.
6. Polavarapu HV, Kulaylat AN, Sun SX, Hamed OH. 100 years of surgical education: the past, present, and future. Bull Am Coll Surg 98(7):22-7, 2013. e-Pub 2013. PMID: 24010218.

Manuals, Teaching Aids, Other Teaching Publications

1. Sun SX, Kass R. Invasive Carcinoma (Ductal, Lobular, All Variants). The SCORE Portal, 2016.
2. . Nurse BEDI (Breast Education Decision Aid Instrument), 2014.
3. Sun SX, Kass R. Breast Cancer – Invasive Carcinoma (Ductal, Lobular, All Variants). The SCORE Portal.
4. Piotrowski M, Singh P, Sun SX. Ductal Carcinoma in Situ. The SCORE Portal.

Other Articles

1. Tang C, Sun SX, Gu C, Li CJ, Xu J, Su KL, Zhou DD, Yu K, Xiao QL, Chen XL Diagnostic and prognostic values of tsRNAs in lung cancer: a meta-analysis. BMC Cancer 25(1):153, 2025. PMID: 39871144.

Editorials

1. Wu Y, Sun SX. Fluid transport comes to the fore. Elife 14, 2025. PMID: 40014042.
2. Sun SX, Messaris E. Soluble CD73 can predict future organ failure in pancreatitis: simple, low cost, but not perfect*. Crit Care Med 42(12):2641-2, 2014. PMID: 25402289.
3. Messaris E, Sun SX. Genetic correlations between murine and human trauma: time to focus only on highly selected genetic pathways. Crit Care Med 42(6):1552-3, 2014. PMID: 24836793.

Abstracts

1. Woodfin AA, Yam C, Teshome M, Kuerer HM, Hunt KK, Meric-Bernstam F, Schaverien M, Barcenas CH, Sun SX. ASO Visual Abstract: Axillary Nodal Metastases Conversion and Perioperative Complications with Neoadjuvant Pembrolizumab Therapy in Triple-Negative Breast Cancer. Ann Surg Oncol. e-Pub 2024. PMID: 38206502.
2. Adesoye T, Everidge S, Chen J, Sun SX, Teshome M, Valero V, Woodward WA, Lucci A. ASO Visual Abstract: Low Rates of Local-Regional Recurrence in Inflammatory Breast Cancer Patients After Contemporary Trimodal Therapy. Ann Surg Oncol 30(10):6241-6242, 2023. e-Pub 2023. PMID: 37578608.
3. Sun SX, Duan Z, Kuerer HM, DeSnyder SM, Cunningham C, Zhao H, Giordano SH. ASO Visual Abstract: Predictors of Emergency Room Visits After Ambulatory Breast Cancer Surgery in the Medicare Population. Ann Surg Oncol 30(3):1699, 2023. e-Pub 2023. PMID: 36622528.
4. Cobb AN, Sun SX. ASO Author Reflections: Inflammatory Breast Cancer with Supraclavicular Nodal Involvement-Favorable Long-Term Outcomes can be Achieved. Ann Surg Oncol 29(10):6393-6394, 2022. e-Pub 2022. PMID: 35842535.
5. Farley CR, Irwin S, Adesoye T, Sun SX, DeSnyder SM, Lucci A, Shaitelman SF, Chang EI, Ueno NT, Woodward WA, Teshome M. ASO Visual Abstract: Lymphedema in Inflammatory Breast Cancer Patients Following Trimodal Treatment. Ann Surg Oncol 29(10):6379-6380, 2022. e-Pub 2022. PMID: 36030283.
6. Cobb AN, Diao K, Teshome M, Lucci A, Ueno NT, Stauder M, Layman RM, Kuerer HM, Woodward WA, Sun SX. ASO Visual Abstract: Long-Term Oncologic Outcomes in Patients with Inflammatory Breast Cancer with Supraclavicular Nodal Involvement. Ann Surg Oncol. e-Pub 2022. PMID: 36104531.
7. Adesoye T, Babayemi O, Postlewait LM, DeSnyder SM, Sun SX, Woodward WA, Ueno NT, Hunt K, Lucci A, Teshome M. ASO Visual Abstract: Inflammatory Breast Cancer at the Extremes of Age. Ann Surg Oncol 29(1):389, 2022. e-Pub 2022. PMID: 34743277.

Book Chapters

1. Bostanci Z, Sun SX, Kass R, Mancino A, Rosenbloom A, Klimberg VS, Bland K. Breast Physiology: Normal and Abnormal Development and Function. In: The Breast: Comprehensive Management of Benign and Malignant Disease. 6th, 2023.
2. Cox S, Kuerer H, Sun SX. Management of Lobular Neoplasia and Ductal Carcinoma in Situ. In: The Breast: Comprehensive Management of Benign and Malignant Disease. 6th, 2023.
3. Sun SX, DeSnyder S. The Surgical Management of Locally Advanced and Stage IV Breast Cancer. In: Spear's Surgery of the Breast: Principles and Art. 4. Wolters Kluwer Health, 2020.
4. Sun, SX, Bostanci Z, Kass R, Mancino A, Rosenbloom A, Klimberg VS, Bland K. Breast Physiology: Normal and Abnormal Development and Function. In: The Breast: Comprehensive Management of Benign and Malignant Disease. 5th edition. Elsevier, 539-56, 2018.
5. Greenleaf E, Kulaylat A, Sun SX, Hollenbeak C. “Large Databases for Health Services Research in Endocrine Surgery.”. In: Medical and Surgical Treatment of Parathyroid Disease. Springer International, 539-56, 2017.